Will LEDGIN molecules be able to play a role in a cure for HIV infection?

Will LEDGIN molecules be able to play a role in a cure for HIV infection?

Bibliographic Details
Main Authors:	Thibault Mesplède, Mark A. Wainberg
Format:	Article
Language:	English
Published:	Elsevier 2016-06-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S235239641630189X

Similar Items

Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence
by: Thibault Mesplède, et al.
Published: (2015-07-01)

The R263K resistance substitution decreases levels of integrated HIV DNA over time
by: Thibault Mesplède, et al.
Published: (2016-05-01)

Impact of LEDGIN treatment during virus production on residual HIV-1 transcription
by: Gerlinde Vansant, et al.
Published: (2019-04-01)

Nonhuman Primates and Humanized Mice for Studies of HIV-1 Integrase Inhibitors: A Review
by: Said A. Hassounah, et al.
Published: (2016-05-01)

Correction to: LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions
by: Belete Ayele Desimmie, et al.
Published: (2020-07-01)

Is Resistance to Dolutegravir Possible When This Drug Is Used in First-Line Therapy?
by: Thibault Mesplède, et al.
Published: (2014-08-01)

LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs.
by: Rik Schrijvers, et al.
Published: (2012-01-01)

HIV drug resistance against strand transfer integrase inhibitors
by: Kaitlin Anstett, et al.
Published: (2017-06-01)

LEDGIN-mediated Inhibition of Integrase–LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV
by: Lenard S. Vranckx, et al.
Published: (2016-06-01)

Correction: LEDGF/p75-Independent HIV-1 Replication Demonstrates a Role for HRP-2 and Remains Sensitive to Inhibition by LEDGINs.
by: Rik Schrijvers, et al.
Published: (2020-09-01)

Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor.
by: Peter K Quashie, et al.
Published: (2015-01-01)

The role of unintegrated DNA in HIV infection
by: Wainberg Mark A, et al.
Published: (2011-07-01)

O1 Towards a block-and-lock strategy: LEDGINs hamper the establishment of a reactivation competent reservoir
by: Gerlinde Vansant, et al.
Published: (2017-09-01)

9 LEDGIN-mediated inhibition of the IN-LEDGF/p75 interaction reduces provirus reactivation from latency
by: Zeger Debyser, et al.
Published: (2017-07-01)

Fitness Impaired Drug Resistant HIV-1 Is Not Compromised in Cell-to-Cell Transmission or Establishment of and Reactivation from Latency
by: Sophie M. Bastarache, et al.
Published: (2014-09-01)

The latest evidence for possible HIV-1 curative strategies
by: Hanh Thi Pham, et al.
Published: (2018-02-01)

The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?
by: Hui Chen, et al.
Published: (2020-07-01)

Erratum for Mesplède et al., “The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration”
by: Thibault Mesplède, et al.
Published: (2018-09-01)

Towards a scalable HIV cure research agenda: the role of co-infections
by: Irini Sereti, et al.
Published: (2015-10-01)

Toward a Cure: Does Host Immunity Play a Role?
by: Jielin Zhang, et al.
Published: (2017-04-01)

The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration
by: Thibault Mesplède, et al.
Published: (2017-04-01)

Autophagy plays an essential role in HIV-1 infection
by: Salasc F, et al.
Published: (2009-09-01)

HIV Infection of Macrophages: Implications for Pathogenesis and Cure
by: Kiera Leigh Clayton, et al.
Published: (2017-05-01)

Block-And-Lock Strategies to Cure HIV Infection
by: Gerlinde Vansant, et al.
Published: (2020-01-01)

Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection
by: Hanh Thi Pham, et al.
Published: (2020-03-01)

The B-Cell Follicle in HIV Infection: Barrier to a Cure
by: Matthew P. Bronnimann, et al.
Published: (2018-01-01)

Can immunotherapy be useful for a « functional cure » of HIV infection?
by: Vanham Guido
Published: (2011-10-01)

HIV transmission should be decriminalized: HIV prevention programs depend on it
by: Wainberg Mark A
Published: (2008-12-01)

Selection of the R263K and H51Y resistance substitutions for DTG causes diminished integration and explains the lack of clinically significant drug resistance to this compound
by: Thibault Mesplède, et al.
Published: (2016-05-01)

Approximate solutions for HIV-1 infection dynamics with cure rate
by: H. Vazquez-Leal, et al.
Published: (2014-01-01)

Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs
by: Bluma G. Brenner, et al.
Published: (2010-11-01)

Gut Microbiome Alterations During HIV/SIV Infection: Implications for HIV Cure
by: Katti R. Crakes, et al.
Published: (2019-05-01)

A Cure for HIV Infection: “Not in My Lifetime” or “Just Around the Corner”?
by: Michael M. Lederman, et al.
Published: (2016-08-01)

Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies
by: Bezawit A. Woldemeskel, et al.
Published: (2020-12-01)

Progress toward curing HIV infection with hematopoietic cell transplantation
by: Petz LD, et al.
Published: (2015-07-01)

Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection
by: Suha Saleh, et al.
Published: (2017-01-01)

In vitro demonstration of a potential role for STING agonist in HIV cure
by: A. Koblansky, et al.
Published: (2019-12-01)

Pathways to HIV cure
by: D. Persaud
Published: (2014-04-01)

HIV PrEP opens the door to STDs. The cons
by: Mark Wainberg
Published: (2016-05-01)

Combination therapies, effectiveness, and adherence in patients with HIV infection: clinical utility of a single tablet of emtricitabine, rilpivirine, and tenofovir
by: Wainberg MA
Published: (2013-02-01)

Cannot write session to /tmp/vufind_sessions/sess_ehkomm8s1ibau8f34t5mim41qe